Mitochondrial alterations including permeability transition (PT) constitute critical events of the apoptotic cascade and are under the control of Bcl-2 related gene products. Here we show that induction of PT is sucient to activate CPP32-like proteases with DEVDase activity and the associated cleavage of the nuclear DEVDase substrate poly(ADP-ribose) polymerase (PARP). Thus, direct intervention on mitochondria using a ligand of the mitochondrial benzodiazepin receptor or a protonophore causes DEVDase activation. In addition, the DEVDase activation triggered by conventional apoptosis inducers (glucocorticoids or topoisomerase inhibitors) is prevented by inhibitors of PT. The protease inhibitor N-benzyloxycabonyl-Val-Ala-Asp-¯uoromethylketone (Z-VAD.fmk) completely prevents the activation of DEVDase and PARP cleavage, as well as the manifestation of nuclear apoptosis (chromatin condensation, DNA fragmentation, hypoploidy). In addition, Z-VAD.fmk delays the manifestation of apoptosis-associated changes in cellular redox potentials (hypergeneration of superoxide anion, oxidation of compounds of the inner mitochondrial membrane, depletion of non-oxidized glutathione), as well as the exposure of phosphatidylserine residues in the outer plasma membrane lea¯et. Although Z-VAD.fmk retards cytolysis, it is incapable of preventing disruption of the plasma membrane during protracted cell culture (12 ± 24 h), even in conditions in which it completely blocks nuclear apoptosis (chromatin condensation and DNA fragmentation). Electron microscopic analysis con®rms that cells treated with PT inducers alone undergo apoptosis, whereas cells kept in identical conditions in the presence of Z-VAD.fmk die from necrosis. These observations are compatible with the hypothesis that PT would be a rate limiting step in both the apoptotic and the necrotic modes of cell death. In contrast, it would be the availability of apoptogenic proteases that would determine the choice between the two death modalities.
Introduction
In contrast to necrosis, apoptosis occurs within the limits of a near-to-intact plasma membrane and involves the action of catabolic enzymes, mainly proteases and nucleases, which act to produce a stereotypic pattern of biochemical and morphological alterations. In spite of this fundamental dierence, recent observations have weakened the paradigmatic antithesis of apoptosis and necrosis. Thus, one early critical event of both modes of cell death appears to be mitochondrial permeability transition (PT). This applies to apoptosis (Kroemer et al., , 1997b and at least to some cases of necrosis (Ankarcrona et al., 1995; Arora et al., 1997; Nieminen et al., 1995 Nieminen et al., , 1996 Nieminen et al., , 1997 Packer et al., 1996; Pastorino et al., 1993 Pastorino et al., , 1994 Pastorino et al., , 1996 Schinder et al., 1996; Snyder et al., 1992; Trost and Lemasters, 1996) . Accordingly, pharmacological inhibition of PT by speci®c drugs acting on mitochondria can interfere with both apoptosis (Marchetti et al., 1996a; Zamzami et al., 1996) and necrosis (Ankarcrona et al., 1995; Arora et al., 1997; Nieminen et al., 1995 Nieminen et al., , 1996 Nieminen et al., , 1997 Packer et al., 1996; Pastorino et al., 1993 Pastorino et al., , 1994 Pastorino et al., , 1996 Schinder et al., 1996; Snyder et al., 1992; Trost and Lemasters, 1996) . Similarly, hyperexpression of the Bcl-2 oncoprotein, which functions as an endogenous inhibitor of PT Zamzami et al., 1996) , can prevent the induction of apoptosis (Cory, 1995; Reed, 1994; Yang and Korsmeyer, 1996) and, in some instances, that of necrosis (Kane et al., 1993; Martinou et al., 1994; Shimizu et al., 1995 Shimizu et al., , 1996a . Bcl-2 has recently also been shown to inhibit the mitochondrial release of apoptogenic factors including cytochrome c (Kluck et al., 1997; Yang et al., 1997) and a dierent activity (AIF) . The apoptosis-inhibitory eect of Bcl-2 on mitochondria does not rely on modulations of respiratory function, as indicated by the facts that (i) apoptosis can occur in cells lacking a respiratory chain due to the r8 mutation; (ii) Bcl-2 inhibits apoptosis of r8 cells (Jacobson et al., 1994) ; (iii) mitochondria from r8 cells undergo PT normally (Marchetti et al., 1996c) ; and (iv) Bcl-2 inhibits the PT of non-respiring mitochondria (Marchetti et al., 1996d) . In contrast, Bcl-2 may function as a direct regulator of membrane potentials and/or permeability (Kroemer, 1997; Schendel et al., 1997) Mitochondrial PT involves the formation of regulated megachannels within a dynamic ensemble of proteins that juxtapose in the inner/outer membrane contact site (Bernardi and Petronilli, 1996; Beutner et al., 1996) . Numerous physiological eectors can regulate PT suggesting that it may allow for the convergence of dierent metabolic and signal transduction pathways into one common death pathway. Such eectors include ions (Ca ceramide), protein thiols, and phosphokinases (Bernardi and Petronilli, 1996; Kroemer et al., 1995 Kroemer et al., , 1997b . PT entails several potentially lethal consequences (Kroemer et al., , 1997b . First, it causes a disruption of the mitochondrial transmembrane potential (DC m ) with a consequent cessation of mitochondrial biogenesis and oxidative phosphorylation (Osborne et al., 1994; Petit et al., 1995; VayssieÁ re et al., 1994) . Second, PT provokes uncoupling of the respiratory chain with hyperproduction of reactive oxygen species (ROS), oxidation of cardiolipin within the inner mitochondrial membrane, and depletion/ oxidation of glutathione (Marchetti et al., 1996a) . Third, PT culminates in the liberation of pre-formed apoptogenic proteins from the mitochondrial intermembrane space. Such apoptogenic proteins include a protease (`apoptosis-inducing factor', AIF), which suces to cause apoptotic changes (chromatin condensation, DNA fragmentation) in a cell-free system Zamzami et al., 1996) , and cytochrome c which activates yet to be characterized cytoplasmic proteases to cause nuclear apoptosis (Fiskum and Murphy, 1996; Liu et al., 1996) . AIF and cytochrome c activate CPP32, one of the signature proteases of apoptosis, in a direct or indirect fashion, respectively (Kroemer et al., 1997b; Liu et al., 1996) .
If PT is involved in both apoptosis and necrosis, what molecular events do determine the mode of cell death? We have addressed this question using inhibitors of proteases activated downstream of PT. It appears that inhibition of such proteases does fully prevent nuclear apoptosis. In contrast, protease inhibition does not interfere with cytolysis. In normal conditions, PT triggers apoptosis. However, in conditions in which protease activation or action is precluded, PT causes necrosis rather than apoptosis. Altogether, the data presented here suggest that PT determines cell death, whereas the availability of downstream proteases dictate the mode of death.
Results and discussion
Mitochondrial permeability transition triggers activation of a CPP32-like protease
The mitochondrial dysfunction which precedes nuclear apoptosis is accompanied by the release of intermembrane proteins into the cytosol. Such proteins include activators of CPP32 (Liu et al., 1996; Susin et al., 1996) . Accordingly, induction of PT using speci®c drugs, namely protoporphyrin IX (a ligand of the peripheral benzodiazepin receptor, one of the proteins contained in the PT pore complex) or mClCCP (a protonophore that disrupts the proton gradient on the inner mitochondrial membrane), triggers activation of an enzyme that cleaves the CPP32 recognition site DEVD in vitro ( Figure 1a ) and the nuclear CPP32 substrate PARP in vivo (Figure 1b) . Prevention of PT by substances targeted to mitochondrial structures such as BA (a ligand of the adenine nucleotide translocator of the inner mitochondrial membrane (Marchetti et al., 1996a) ) or CMXRos (a thiol-reactive agent targeted to the mitochondrial matrix, (Marchetti et al., 1997) ) inhibits the DEVDase activation by physiological apoptosis inducers such as the glucocorticoid receptor agonist dexamethasone (DEX) or the topoisomerase I inhibitor etoposide (Figure 1 ). Thus, in addition to stabilizing the DC m (Marchetti et al., 1996a (Marchetti et al., , 1997 and data not shown), these agents prevent the apoptosis-associated activation of CPP32-like proteases.
These data provide direct evidence that PT is sucient to provoke activation of one or several CPP32-like proteases. Moreover, PT is necessary to induce activation of CPP32-like proteases, at least in the two models of apoptosis studied here. This is in line with the fact that the Bcl-2-controlled event of the apoptotic cascade, presumably PT and/or mitochondrial release of apoptogenic factors (Kluck et al., 1997; Susin et al., 1996; Yang et al., 1997) , is located upstreamof CPP32 activation (Chinnaiyan et al., 1996) .
Z-VAD.fmk prevents the PT-mediated activation of a CPP32-like protease and concomitantly blocks nuclear apoptosis
It has been shown that Z-VAD.fmk prevents the proteolytic activation (but not the action) of CPP32 during apoptosis (Slee et al., 1996) . Accordingly, Z-VAD.fmk, an inhibitor of ICE-like proteases and AIF, prevents both the activation of the DEVDase ( Figure  1a ) and the cleavage of the CPP32 substrate PARP induced by mClCCP, PPIX, DEX or etoposide ( Figure  1b ). This is not due to the inhibition of PT as such, since Z-VAD.fmk fails to prevent the initial DC m collapse induced by these agents (see below). As a control, Z-FA.fmk, a structural analog of Z-VAD.fmk in which the amino acid sequence VAD has been replaced, does not aect PARP cleavage (Figure 1b) . In parallel to its eect on CPP32-like proteases, Z-VAD.fmk (but not Z-FA.fmk) completely suppresses the induction of nuclear apoptosis (Figures 1 and 2a) . In all circumstances, a strict correlation is observed between cytosolic DEVDase activation and nuclear apoptosis assessed via dierent methods (hypoploidy in Figure 1a , PARP cleavage in Figure 1b , TUNEL assay and DNA electrophoresis in Figure 2a ), both of which appear to be consequences of PT.
In conclusion, one or several Z-VAD.fmk-inhibitable proteases link mitochondrial permeability transition to later nuclear apoptosis in the living cell. These data con®rm and extend earlier reports obtained in cell-free systems .
Z-VAD.fmk partially inhibits the cytoplasmic manifestations of apoptosis
As outlined in the Introduction, PT has major eects on intermediate metabolism. We have tested the eect of Z-VAD.fmk on the mitochondrial and cytoplasmic changes caused by PT. As to be expected, Z-VAD.fmk fails to prevent the disruption of the DC m induced by the PT inducers mClCCP or PPIX (Figure 2b) . Surprisingly, Z-VAD.fmk (but not Z-FA.fmk, data not shown) has a marked inhibitory eect on alterations in cellular redox potentials induced by mClCCP or PPIX: generation of superoxide anions (measured with HE, Figure 2b ), depletion of nonoxidized glutathione (detected by MCB, Figure 2c) , oxidation of cardiolipin in the inner mitochondrial membrane (quanti®ed with NAO, Figure 2c ). In addition, Z-VAD.fmk (but not Z-FA.fmk) partially prevents another hallmark of apoptosis, namely the exposure of phosphatidylserine (PS) residues on the surface of the plasma membrane (Figure 2d ). These ®ndings suggest an intricate relationship between protease activation and redox regulation downstream of PT, in line with the speculation that protease activation may engage in a self-amplifying positive feedback loop through eects on mitochondria Susin et al., 1996) . It has to be stated, however, that the Z-VAD.fmk-mediated inhibition of redox-associated and membrane changes is less pronounced than that of nuclear apoptosis. Thus, even in conditions in which nuclear apoptosis is completely inhibited (52% hypoploid or TUNEL + cells, Figures 1a and 2a) , the eects of Z-VAD.fmk on the cytoplasmic consequences of PT are only partial (Figure 2b ± d) . The eect of Z-VAD.fmk on nonnuclear manifestations of apoptosis remains partial even when the dose of Z-VAD.fmk is increased (not shown).
Altogether these data indicate that Z-VAD.fmkinhibitable proteases play a major role in the coordination of the apoptosis eector phase downstream of PT. Such Z-VAD.fmk-sensitive proteases are an absolute requirement of nuclear apoptosis and DEVDase activation. Moreover, they contribute to the manifestation of two additional post-PT features of apoptosis: redox imbalance and PS exposure at the cell surface.
Mitochondrial permeability transition causes necrosis when the apoptotic mode of death is prevented Z-VAD.fmk fully prevents nuclear apoptosis induced by a variety of dierent stimuli (DEX, etoposide, mClCCP, PPIX), and this eect is durable. Cells cultured in the presence of Z-VAD.fmk fail to manifest hypoploidy or oligonucleosomal DNA fragmentation (Figure 3b ) for periods as long as 12 or 24 h. Although Z-VAD.fmk fails to prevent the initial partial DC m loss induced by DEX (Figure 3a) or etoposide (not shown), it does delay the subsequent complete DC m collapse and consequent superoxide anion generation (Figure 3a and Marchetti et al., 1996b) , exactly as this is the case when PT is induced by direct intervention on mitochondria (Figure 2b) . However, the Z-VAD.fmk-mediated inhibition of nuclear apoptosis does not suce to maintain the viability of cells during protracted incubation periods. Whereas Z-VAD.fmk fully preserves the integrity of nuclear DNA for up to 24 h (Figure 3b and c) , it fails to protect cells against cytolysis induced by direct inducers of PT (PPIX, mClCCP) or classical inducers of apoptosis such as the glucocorticoid receptor agonist DEX and the topoisomerase type II inhibitor etoposide (Figure 3b and d) . This non-apoptotic cell death possesses several electron microscopic features of necrosis: disruption of the plasma membrane, vacuolization, and hydropsis of mitochondria. In contrast, pronounced chromatin condensation is not observed (Figures 4 and 5) . Disruption of plasma membrane integrity induced by etoposide (Figure 5a ) or DEX (not shown), in the absence of Z-VAD.fmk, oers the typical picture of secondary necrosis (that is necrosis after apoptosis), in the sense that it only aects cells with condensed, homogeneously electron-dense nuclei. In contrast, in the presence of Z-VAD.fmk, cytolysis oers a markedly dierent aspect and aects cells which still lack features of advanced nuclear apoptosis (Figures 4d and 5b ). This set of data indicates that, instead of preventing cell death as such, the inhibition of postmitochondrial protease activation causes a shift from the apoptotic to a non-apoptotic (necrotic?) mode of cell death.
Concluding remarks
Although apoptosis has been initiall de®ned by confronting it with necrosis (Kerr et al., 1972) , several observations shed doubts on the functional opposition between these two types of cell death. A number of pathologies which were previously thought to involve primary necrosis, are now described to involve apoptosis: apoplexy (Martinou et al., 1994) , myocardial infarction (Itoh et al., 1995) , and ischemia/ reperfusion damage (Sasaki et al., 1996) . More importantly, hyperexpression of the apoptosis-inhibitory oncoprotein Bcl-2 inhibits several examples of necrotic cell death: kainate-induced neuronal necrosis (Kane et al., 1993) , occlusion of the midbrain artery (Martinou et al., 1994) , anoxia (Shimizu et al., 1995) , and chemical hypoxia (Shimizu et al., 1996a) . At least in some instances, PT constitutes a molecular event that is involved in both apoptosis and in many Figure 2 Eect of PT inducers and/or Z-VAD.fmk on nuclear DNA fragmentation, mitochondrial parameters, cellular redox potentials, and plasma membrane integrity. Thymocytes were cultured for 6 h in the presence of the PT inducers PPIX or mClCCP and/or the protease inhibitors Z-VAD.fmk or Z-FA.fmk.(a) Determination of DNA fragmentation. Nuclear DNA fragmentation was determined on a per-cell-basis using the TUNEL technique. Alternatively, internucleosomal DNA fragmentation in mono-or oligomers of 200 bp was assessed by agarose gel electrophoresis followed by ethidium bromide staining. (b) Quantitation of DC m and superoxide anion generation. Cells were subjected to simultaneous staining with the DC m -sensitive dye DiOC (6) 3 and hydroethidine (HE). HE, which is non-¯uorescent, reacts with superoxide anion to form the¯uorescent product ethidium. Numbers refer to the percentage of cells encountered in each quadrant. (c) Determination of non-oxidized glutathione and cardiolipin using monochlorobimane (MCB) and nonylacridine orange (NAO), respectively. (d) Determination of plasma membrane features of cell death. Cells were stained with the vital dye ethidium bromide (EthBr) and an annexin V-FITC conjugate speci®cally detecting the exposure of phosphatidylserine (PS) residues at the cell surface. Results (representative for three to ®ve experiments) are not shown for the control substance Z-FA.fmk, which does not aect any of the measured parameters examples of necrosis (Ankarcrona et al., 1995; Arora et al., 1997; Bernardi and Petronilli, 1996; Kroemer et al., 1995 Kroemer et al., , 1997b Nieminen et al., 1995 Nieminen et al., , 1996 Nieminen et al., , 1997 Packer et al., 1996; Pastorino et al., 1993 Pastorino et al., , 1994 Pastorino et al., , 1996 Schinder et al., 1996; Snyder et al., 1992; Trost and Lemasters, 1996) . Thus, paradoxically, the early phases of both apoptosis and necrosis may involve a common pathway.
The ®ndings reported in this paper may contribute to resolve this apparent paradox. It appears that the Figure 3 Z-VAD.fmk prevents nuclear apoptosis but fails to prevent cytolysis. (a) Eect of Z-VAD.fmk on the mitochondrial phase of apoptosis. Thymocytes were cultured in the presence of DEX and/or Z-VAD.fmk during 6 or 12 h, followed by staining with the potentialsensitive dye DiOC 6 (3) and the superoxide anion-reactive probe HE. (b) Eect of Z-VAD.fmk on DEX-induced apoptosis and cytolysis. After 12 h of culture in the presence of the indicated agents, cells were either ®xed with ethanol, followed by determination of their DNA content, or were stained with PI to determine the frequency of apoptotic (PI availability of apoptogenic proteases activated subsequent to mitochondrial PT dictates the mode of cell death. Whenever such proteases are present in a cell and become activated, apoptosis will ensue. However, in the absence of such protease activation, the cell will die from necrosis subsequent to PT. Accordingly, hyperexpression of Bax, which triggers a DC m disruption (presumably via a direct eect on mitochondria (Zha et al., 1996) causes a non-apoptotic cell death in the presence of Z-VAD.fmk (Xiang et al., 1996) . Overexpression of the Bax homologue Bak also causes non-apoptotic cytolysis in the presence of Z-VAD.fmk (McCarthy et al., 1997) . In contrast, inhibition of the mitochondrial phase of cell death by overexpressing Bcl-2 (Boise and Thompson, 1997; Zamzami et al., 1995 Zamzami et al., , 1996 or using mitochondrion-targeted drugs such as BA does maintain cell viability (Marchetti et al., 1996a (Marchetti et al., , 1997 , and data not shown). Of note, at least in some cases caspase activation is not sucient to cause apoptosis (Boise and Thompson, 1997; Miossec et al., 1997) , suggesting that the mitochondrial phase of the process is an obligatory requirement for the acquisiton of the apoptotic phenotype.
The notion that PT can trigger both apoptosis and necrosis is also compatible with the ®nding that many drugs induce necrosis at high doses and apoptosis at lower (`subnecrotic') doses (Kroemer, 1995) . Thus, when PT is induced in a massive, rapid fashion heavily compromising cellular metabolism, necrosis (primary disruption of the plasma membrane) would occur before apoptogenic proteases are activated and can act on nuclear and cytoplasmic substrates. Accordingly, manipulations of energy metabolism (inhibition of the respiratory chain; provision or withdrawal of substrates for glycolysis) can shift the balance between apoptosis and necrosis (Nicotera and Leist, 1997; Shimizu et al., 1996b) . In contrast, induction of PT in a more smooth, protracted fashion would allow for the activation and action of speci®c protases (AIF, CPP32 and perhaps other downstream proteases) before ATP depletion causes cell death. In other terms, the intensity of the PT-inducing stimulus would determine which among the two major consequences of PT wins the race (i): a bioenergetic catastrophe culminating in necrosis or (ii) the activation/action of apoptogenic proteases. In addition, the availablity of pre-formed apoptogenic proteases (and their endogenous inhibitors?) would dictate the propensity of cells to die from apoptosis versus necrosis. However, one rate-limiting step of both apoptosis and at least some cases of necrosis would be mitochondrial alterations including PT. This concept may have far-reaching implications for our understanding of cell death, as well as for the future development of cytoprotective drugs.
Materials and methods

Induction and inhibition of apoptosis
Thymocytes from female Balb/c mice (1610 6 cells/ml in RPMI 1640 supplemented with 10% FCS, L-glutamine and antibiotics) were cultured for the indicated period in the presence of apoptosis inducers or inhibitors: carbonyl cyanide m-chlorophenylhydrazone (mClCCP, 100 mM), protoporphyrin IX (PPIX, 300 mM), dexamethasone (DEX, 10 mM), etoposide (10 mM; St Louis, MO), bongkrekic acid (BA, 50 mM; kindly provided by Dr Duine, Delf University), chloromethyl-X-rosamine (CMXRos, 2 mM; Molecular Probes, Eugen, OR), Nbenzyloxycarbonyl-Phe-Ala-¯uoromethylketone (Z-FA.fmk, 50 mM) and/or N-benzyloxycarbonyl-Val-AlaAsp-¯uoromethylketone (Z-VAD.fmk, 50 mM; Enzyme Systems, Dublin, CA).
Cyto¯uorometric analyses
Following published protocols (Kroemer et al., 1997a; Marchetti et al., 1996a; Zamzami et al., 1995) , the following¯uorochromes were employed to determine dierent apoptosis-associated changes: 3,3'dihexyloxacarbocyanine iodide (DiOC (6) 3, 20 nM) for DC m quantification; hydroethidine (HE, 4 mM) for the determination of superoxide anion generation; monochlorobimane (MCB, 50 mM) as a probe of non-oxidized glutathione; nonylacridine orange (NAO, 100 nM; Molecular Probes) for measurement of cardiolipin oxidation; annexin V-FITC (1 mg/ml; Nexius Research, Hoeven, The Netherlands) for determination of phosphatidyl serine (PS) exposure on the outer plasma membrane; FITC-dUTP for incorporation into strand breaks using the TUNEL method; or the vital dyes ethidium bromide (EthBr; 200 ng/ml) and propidium iodine (PI; 2 mg/ml). The frequency of subdiploid cells was determined by PI staining of ethanol-permeabilized cells (Kroemer et al., 1997a) .
DNA fragmentation analysis and electron microscopy DNA fragmentation (5610 5 cells/lane) was determined by agarose gel electrophoresis (Kroemer et al., 1997a) . Electron microscopy was performed on osmiumtetroxide/ lead citrate-stained ultrathin sections as described (Marchetti et al., 1996a). Determination of DEVDase activity and PARP cleavage Cytosols (4610 6 cells/100 ml in CFS buer: 220 mM mannitol; 68 mM sucrose, 2 mM NaCl, 2.5 mM PO 4 H 2 K, 0.5 mM EGTA, 2 mM MgCl 2 , 5 mM pyruvate, 0.1 mM phenylmethyl sulfonyl¯uoride [PMSF] , 1 mM dithiotreitol, 10 mM HEPES-NaOH, pH 7.4 buer; supplemented with additional protease inhibitors: 1 mg/ml leupeptin, 1 mg/ml pepstatin A, 5 mg/ml antipain, 1 mg/ml chymopapain) were prepared by ®ve freeze/thaw cycles in liquid nitrogen and at 378C, followed by centrifugation (1.5610 5 g, 48C, 1 h) as described (Enari et al., 1995) . The capacity of cytosols to cleave the CPP32 recognition site DEVD was determined using Ac-DEVD-amino-4-methylcoumarin (10 mM; Bachem, Basel, Switzerland) as¯uorogenic substrate (Nicholson et al., 1995) . The degree of poly(ADP-ribose) polymmerase (PARP) cleavage was determined by immunoblots (1610 6 cells/lane), using the monoclonal antibody C2-10 (purchased from Guy Poirier, Montreal University, Canada) as a speci®c probe (Lazebnik et al., 1994) .
Abbreviations AIF, apoptosis-inducing factor; BA, bongkrekic acid; CMXRos, chloromethyl X-rosamine; DEX, dexamethasone; DiOC 6 (3), 3,3'dihexyloxacarbocyanine iodide; DC m , mitochondrial transmembrane potential; Eth, ethidium; H E , h y d r o e t h i d i n e ; M C B , m o n o c h l o r o b i m a n e ; mClCCP,carbonyl cyanide m-chlorophenylhydrazone; NAO, nonyl acridineorange; PARP, poly (ADP-ribose) polymerase; PT, permeability transition; ROS, reactive oxygen species; TdT, terminal deoxynucleotidyltransferase; Z-FA.fmk, N-benzyloxycarbonyl-Phe-Ala-fluoromethylketone; Z-VAD.fmk, N-benzyloxycarbonyl-Val-Ala-Aspuoromethylketone
